Heath Insurers Are Denying More Drug Claims, Data Shows

The article highlights a concerning trend in the health insurance industry - the increasing denial of drug claims by major private insurers. According to the data presented, there has been a steady rise in the number of rejected claims, providing a rare glimpse into the opaque nature of this process. The article suggests that this issue disproportionately affects patients who rely on specialty drugs, which are often more expensive and complex. Insurers, motivated by cost-cutting measures, are becoming more stringent in their approval criteria, leaving many patients without the necessary coverage for their prescribed treatments. The article underscores the importance of transparency and accountability in the healthcare system, as these denied claims can have significant consequences for individuals' access to essential medications. The data reveals the need for further investigation and potential policy changes to ensure that patients receive the coverage they are entitled to and can afford the treatments they require.